Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study - Concepedia

Concepedia

Publication | Closed Access

Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study

103

Citations

28

References

2008

Year

David Taïeb, F. Sébag, Karine Baumstarck, Cécile Fortanier, Bardia Farman-Ara, C. De Micco, J.C. Vaillant, S. Thomas, B. Conte‐Devolx, Anderson Loundou,

Clinical Endocrinology

Abstract

rhTSH preserves QoL of patients undergoing RRA with similar rates of ablation success compared to hypothyrodism. However, there is a wide heterogeneity in the clinical impact of hypothyroidism.

References

	Year	Citations

Page 1